donepezil has been researched along with Developmental Psychomotor Disorders in 5 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Donepezil may ameliorate visual hallucinations in PD patients, but controlled, double-blind trials are necessary to further clarify the effect of this drug on VHs in PD." | 5.32 | The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease. ( Inoue, K; Kono, Y; Kurita, A; Ochiai, Y; Suzuki, M, 2003) |
| "Down syndrome is probably believed too special and therefore many clinicians seems to hesitate to attend them or scare to give wrong treatment." | 2.46 | [Care continuity for patients with Down syndrome during transition from childhood to adulthood]. ( Hasegawa, T, 2010) |
| "Donepezil may ameliorate visual hallucinations in PD patients, but controlled, double-blind trials are necessary to further clarify the effect of this drug on VHs in PD." | 1.32 | The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease. ( Inoue, K; Kono, Y; Kurita, A; Ochiai, Y; Suzuki, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, T | 1 |
| Kurita, A | 1 |
| Ochiai, Y | 1 |
| Kono, Y | 1 |
| Suzuki, M | 1 |
| Inoue, K | 1 |
| Olazarán, J | 1 |
| Muñiz, R | 1 |
| Reisberg, B | 1 |
| Peña-Casanova, J | 1 |
| del Ser, T | 1 |
| Cruz-Jentoft, AJ | 1 |
| Serrano, P | 1 |
| Navarro, E | 1 |
| García de la Rocha, ML | 1 |
| Frank, A | 1 |
| Galiano, M | 1 |
| Fernández-Bullido, Y | 1 |
| Serra, JA | 1 |
| González-Salvador, MT | 1 |
| Sevilla, C | 1 |
| Lindner, MD | 1 |
| Hogan, JB | 1 |
| Hodges, DB | 1 |
| Orie, AF | 1 |
| Chen, P | 1 |
| Corsa, JA | 1 |
| Leet, JE | 1 |
| Gillman, KW | 1 |
| Rose, GM | 1 |
| Jones, KM | 1 |
| Gribkoff, VK | 1 |
| Miyaoka, T | 1 |
| Seno, H | 1 |
| Yamamori, C | 1 |
| Inagaki, T | 1 |
| Itoga, M | 1 |
| Tsubouchi, K | 1 |
| Horiguchi, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effectiveness of Home-based Electronic Cognitive Therapy in Alzheimer's Disease[NCT02521558] | 30 participants (Actual) | Interventional | 2015-09-30 | Terminated (stopped due to Enrollment was halted early because of low adherence to the intervention.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for donepezil and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
[Care continuity for patients with Down syndrome during transition from childhood to adulthood].
Topics: Adolescent; Adult; Aged; Alzheimer Disease; Child; Comprehensive Health Care; Continuity of Patient | 2010 |
1 trial available for donepezil and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Caregivers; Cholinesterase Inhibitors; Cognition Disorde | 2004 |
3 other studies available for donepezil and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Female; Hallucin | 2003 |
Donepezil primarily attenuates scopolamine-induced deficits in psychomotor function, with moderate effects on simple conditioning and attention, and small effects on working memory and spatial mapping.
Topics: Animals; Attention; Cholinesterase Inhibitors; Cognition Disorders; Conditioning, Psychological; Don | 2006 |
Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Dystonia; Humans; Indans; Male; Middle Aged | 2001 |